Financial Consulate »

Amylyx Pharmaceuticals shares owned by Financial Consulate

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Financial Consulate from 13F filings

Historical chart of Financial Consulate investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Financial Consulate consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Financial Consulate

Quarter filed Position value Share count Share price at filing
2025-09-30 $340 25 13.60

More positions owned by Financial Consulate

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Dimensional Etf Trust Us High Profitab (DUHP)
Pimco Equity Ser Rafi Dyn Multi (MFDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Dimensional Etf Trust Intl High Profit (DIHP)
Schwab Strategic Tr Fundamental Us B (FNDB)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Apple (AAPL)
T Rowe Price Etf Cap Appreciation (TCAF)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Mccormick & Co Com Non Vtg (MKC)
Schwab Strategic Tr Fundamental Intl (FNDF)

View all positions for Financial Consulate

Top funds holding Amylyx Pharmaceuticals

FMR
Perceptive Advisors
BlackRock
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Saturn V Capital Management
Commodore Capital
First Light Asset Management
Point72 Asset Management
Henderson Group
Driehaus Capital Management
Almitas Capital
Goldman Sachs Group
Paradigm Biocapital Advisors

View all funds holding Amylyx Pharmaceuticals